Glialign was established in 2018 to take forward the work of UCL academics in engineering live neural tissue.
Our current project has been funded by the UCL Technology Fund, UK Innovation and Science: Seed Fund (UKI2S) and Innovate UK.
Our founders James Phillips and John Sinden are currently optimising a method for producing a living nerve growth guide designated “EngNT”, which is intended as an ‘off-the-shelf’ nerve replacement – primarily for peripheral nerve repair. This represents an innovative engineering solution to an unmet clinical need.
Our latest news
James Phillips and John Sinden attended the 5th International Symposium on Peripheral Nerve Regeneration held in Porto, Portugal on 8th-9thJuly 2019. James Phillips gave a Keynote Lecture “Preclinical proof of concept testing for ‘off the shelf’ living engineered neural tissue” in which he presented the results from Glialign’s recent preclinical experiment conducted at UCL to an audience […]